✦ LIBER ✦

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

✍ Scribed by Piccart-Gebhart, Martine J.; Procter, Marion; Leyland-Jones, Brian; Goldhirsch, Aron; Untch, Michael; Smith, Ian; Gianni, Luca; Baselga, Jose; Bell, Richard; Jackisch, Christian; Cameron, David; Dowsett, Mitch; Barrios, Carlos H.; Steger, Günther; Huang, Chiun-Shen; Andersson, Michael; Inbar, Moshe; Lichinitser, Mikhail; Láng, István; Nitz, Ulrike; Iwata, Hiroji; Thomssen, Christoph; Lohrisch, Caroline; Suter, Thomas M.; Rüschoff, Josef; Sütő, Tamás; Greatorex, Victoria; Ward, Carol; Straehle, Carolyn; McFadden, Eleanor; Dolci, M. Stella; Gelber, Richard D.

Book ID: 120631060
Publisher: Massachusetts Medical Society
Year: 2005
Tongue: English
Weight: 149 KB
Volume: 353
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa052306

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2–47 Trastuzumab After Adjuvant Chemothe

2–47 Trastuzumab After Adjuvant Chemotherapy in HER2-Positive Breast Cancer

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

2-year follow-up of trastuzumab after ad

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

✍ Ian Smith; Marion Procter; Richard D Gelber; Sébastien Guillaume; Andrea Feyerei 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 183 KB

0154 TEACH: Phase III study of lapatinib

0154 TEACH: Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-positive breast cancer

✍ B. Moy; J.D. Maltzman; E. Rappold; L. Nicolodi; L.S. Williams; P.E. Goss 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Treatment with trastuzumab for 1 year af

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

✍ Luca Gianni; Urania Dafni; Richard D Gelber; Evandro Azambuja; Susanne Muehlbaue 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 322 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Trastuzumab plus Adjuvant Chemotherapy f

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

✍ Romond, Edward H.; Perez, Edith A.; Bryant, John; Suman, Vera J.; Geyer, Charles 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 162 KB